Concepedia

Göran Duker

GD

29

Publications

2.3K

Citations

25

H-Index

1983

Active since

Affiliations

AstraZeneca (Sweden)(Current)

University Medical Center Utrecht

Ericsson (Sweden)

Lund University

Göran Duker is an author at AstraZeneca (Sweden) specializing in medicine, electrophysiology, and physiology.

Top concepts

Publications per year

1983–2012

29

Publications

29

Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic

Luc M. Hondeghem, Leif Carlsson, Göran Duker · Circulation · 2001 · 499 citations

QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit

Leif Carlsson, Olle Almgren, Göran Duker · Journal of Cardiovascular Pharmacology · 1990 · 236 citations

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

Lena Carlsson, Christoffer Abrahamsson, Bert Andersson et al. · Cardiovascular Research · 1993 · 214 citations

Electrophysiological Characterization of the Prokinetic Agents Cisapride and Mosapride in Vivo and in Vitro: Implications for Proarrhythmic Potential?

Leif Carlsson, Gregory Amos, Birgit Andersson et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 158 citations

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG

Malin K.B. Jonsson, Marc A. Vos, Gary R. Mirams et al. · Journal of Molecular and Cellular Cardiology · 2012 · 137 citations · Full text

, , +10

Rows per page

1–5 of 29